AVII - AVI BioPharma (Cancer Vaccine) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AVII - AVI BioPharma (Cancer Vaccine)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: bob zagorin	3/10/2007 2:08:49 PM
	of 284

and this from barron's.. "....Those stocks were AVI Biopharma (ticker: AVII), a small biotechnology outfit that had soared in 2005 on hopes for its anti-viral drug that had potential to treat avian flu. The other was Skyterra Communications (SKYT), which owned a piece of a nationwide satellite and terrestrial mobile-phone venture. While relatively obscure, the stocks were not totally unknown. AVI's potential attracted the attention of Barron's Andrew Bary in 2005, who reported about the company's development of a bird-flu drug (by which time Obama's broker had sold his position). Bary also reported the company's opportunistic follow-on stock offering shortly thereafter, which took advantage of the jump in the share price following the bullish Barron's article, but also dismayed its backers because of the resulting dilution. Bary also reported some favorable test results in January 2006 but also stressed the speculative nature of AVI's shares. As it turns out, AVI was on the 52-week low list Tuesday and inched up two cents Wednesday to $2.48 -- around the same level where Obama bought 2000 shares in 2005 and a buck below where he got out...."

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next